Evofem Biosciences, Inc.Evofem Biosciences, Inc.Evofem Biosciences, Inc.

Evofem Biosciences, Inc.

No trades
See on Supercharts
Market capitalization
‪730.44 K‬USD
‪52.98 M‬USD
‪18.22 M‬USD
‪45.93 M‬
Beta (1Y)
−0.31

About Evofem Biosciences, Inc.

CEO
Saundra L. Pelletier
Website
Headquarters
San Diego
Employees (FY)
37
Founded
2007
FIGI
BBG007BW54K5
Evofem Biosciences, Inc. is a commercial-stage biopharmaceutical company, which develops and commercializes innovative products to unmet needs in women's sexual and reproductive health. Its product includes Phexxi (lactic acid, citric acid and potassium bitartrate), a hormone-free vaginal gel and EVO100, an investigational drug, which is used for urogenital Chlamydia trachomatis and Neisseria gonorrhoeae infection in women. The company was founded in 2007 and is headquartered in San Diego, CA.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of EVFM is 0.0159 USD — it has increased by 3.25% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Evofem Biosciences, Inc. stocks are traded under the ticker EVFM.
Evofem Biosciences, Inc. is going to release the next earnings report on May 8, 2024. Keep track of upcoming events with our Earnings Calendar.
EVFM stock is 6.00% volatile and has beta coefficient of −0.31. Check out the list of the most volatile stocks — is Evofem Biosciences, Inc. there?
EVFM earnings for the last quarter are 0.10 USD per share, whereas the estimation was −7.50 USD resulting in a 101.33% surprise. The estimated earnings for the next quarter are −0.61 USD per share. See more details about Evofem Biosciences, Inc. earnings.
Evofem Biosciences, Inc. revenue for the last quarter amounts to ‪5.11 M‬ USD despite the estimated figure of ‪21.70 M‬ USD. In the next quarter revenue is expected to reach ‪5.19 M‬ USD.
Yes, you can track Evofem Biosciences, Inc. financials in yearly and quarterly reports right on TradingView.
EVFM stock has fallen by 0.62% compared to the previous week, the month change is a 36.40% fall, over the last year Evofem Biosciences, Inc. has showed a 99.56% decrease.
EVFM net income for the last quarter is ‪−2.11 M‬ USD, while the quarter before that showed ‪66.00 M‬ USD of net income which accounts for −103.20% change. Track more Evofem Biosciences, Inc. financial stats to get the full picture.
Today Evofem Biosciences, Inc. has the market capitalization of ‪730.44 K‬, it has decreased by 13.94% over the last week.
No, EVFM doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, EVFM shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Evofem Biosciences, Inc. stock right from TradingView charts — choose your broker and connect to your account.
EVFM reached its all-time high on Aug 4, 2015 with the price of 169277.5127 USD, and its all-time low was 0.0122 USD and was reached on Feb 28, 2024.
See other stocks reaching their highest and lowest prices.
As of Apr 23, 2024, the company has 37.00 employees. See our rating of the largest employees — is Evofem Biosciences, Inc. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Evofem Biosciences, Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Evofem Biosciences, Inc. stock shows the sell signal. See more of Evofem Biosciences, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Evofem Biosciences, Inc. EBITDA is ‪−16.07 M‬ USD, and current EBITDA margin is −88.19%. See more stats in Evofem Biosciences, Inc. financial statements.